On November 3rd 2020, Australian government announced that introducers (manufacturers or importers) of cosmetic toothpaste or oral hygiene products need to register their business only if their products meet the requirement of Therapeutic Goods (Excluded Goods) Determination 2018. The ingredients used in cosmetic toothpaste or oral hygiene should categorized in any of the 5 main categories under AICIS.
Cosmetic toothpaste or oral hygiene products are those which meet the following criteria:
The registrants should keep records for 5 years of chemical introductions even after stopping introductions in Australia territory, to confirm that they comply with laws.
Registrants must submit annual declarations regardless the introduction category by 30 November after end of every registration year.
If toothpaste and oral hygiene products are medicines or marketed as having therapeutic effects, then they are classed as ‘therapeutic’ goods and regulated under Therapeutic Goods Administration (TGA) doesn’t have any implications under AICIS.
Chemicals with CAS number 169118-66-5 and 144093-88-9 have been added to Australian Inventory of Industrial Chemicals in accordance with section 82 of the Industrial Chemicals Act 2019 after completion of 5 years since the assessment certificates were issued.
Information on Schedule 2,3,4 and 8:
Schedule 2: Pharmacy Medicine – Substances, the safe use of which may require advice from a pharmacist and which should be available from a pharmacy or, where a pharmacy service is not available, from a licensed person.
Schedule 3:Pharmacist Only Medicine – Substances, the safe use of which requires professional advice but which should be available to the public from a pharmacist without a prescription.
Schedule 4: Prescription Only Medicine, or Prescription Animal Remedy – Substances, the use or supply of which should be by or on the order of persons permitted by State or Territory legislation to prescribe and should be available from a pharmacist on prescription.
Schedule 8: Controlled Drug – Substances which should be available for use but require restriction of manufacture, supply, distribution, possession and use to reduce abuse, misuse and physical or psychological dependence.